The science and technology of KXTbio is built on more than two decades of research on the biological mechanisms of GPCR and GTPase signalling pathways originating from the laboratory of Professor John Sondek as part of the University of North Carolina At Chapel Hill. His research is focused on understanding protein complexes involved in signal transduction cascades as potential targets for new therapeutics against cancer and neurological diseases.
KXTbio is a leader in the development and application of new technical products focused on the expression of 95% pure and highly active proteins and mammalian specific biosensors. In addition, KXTbio provides drug discovery platforms focused on the crystallogrophy technology created in the Sondek lab.
